Related Experiment Video
Updated: Aug 18, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease
Eman Nagy1, Mahmoud M Sobh1, Mohamed Abdalbary1
1Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt.
Adynamic bone (ADB) is increasingly prevalent in chronic kidney disease (CKD), but its role as a disease or adaptive mechanism remains unclear. Further research is needed to understand its impact on bone health and survival in CKD patients.
Area of Science:
- Nephrology
- Bone Metabolism
- Pathophysiology
Background:
- Renal osteodystrophy (ROD) is a common complication in chronic kidney disease (CKD).
- Adynamic bone (ADB) is characterized by suppressed bone formation and low cellularity, with increasing prevalence in early CKD.
- The exact nature of ADB—whether a disease, adaptive mechanism, or transitional stage—is not well understood.
Purpose of the Study:
- To review current knowledge on Adynamic Bone (ADB).
- To discuss the impact of ADB on bone health, fracture risk, vascular calcification, and survival in CKD patients.
- To emphasize preventive and management strategies for ADB in CKD.
Main Methods:
- Literature review of up-to-date knowledge on Adynamic Bone (ADB).
- Discussion of pathogenesis, clinical impact, and management strategies for ADB in CKD.
Main Results:
- Evidence suggests an increasing prevalence of ADB, particularly in early CKD.
- ADB's role in pathogenesis involves factors like age, diabetes, malnutrition, uremia, and iatrogenic causes.
- The clinical impact of ADB on bone health, fracture risk, vascular calcification, and survival requires further investigation.
Conclusions:
- The precise role of ADB in CKD remains uncertain, with ongoing debate about its pathological or adaptive nature.
- Effective management and prevention strategies for ADB are crucial for CKD patient care.
- More research is essential to clarify the implications of ADB in patients with chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
What is the Skeletal System?
Chronic Kidney Disease IV: Nursing Management

